Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014647 |
| CAS No | NA |
| Mol.F. | C18H19N5O2 |
| Mol.Wt. | 337.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014648 |
| CAS No | NA |
| Mol.F. | C9H10N6O4 |
| Mol.Wt. | 266.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014649 |
| CAS No | NA |
| Mol.F. | C25H47N7O11 |
| Mol.Wt. | 621.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014650 |
| CAS No | NA |
| Mol.F. | C25H46N8O12 |
| Mol.Wt. | 650.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014651 |
| CAS No | NA |
| Mol.F. | C12H20N6O3S2 |
| Mol.Wt. | 360.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014652 |
| CAS No | NA |
| Mol.F. | C12H19N7O4S2 |
| Mol.Wt. | 389.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014653 |
| CAS No | NA |
| Mol.F. | C12H20N6O3S2 |
| Mol.Wt. | 360.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014654 |
| CAS No | NA |
| Mol.F. | C21H20N4O4 |
| Mol.Wt. | 392.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014655 |
| CAS No | NA |
| Mol.F. | C16H23N3O2 |
| Mol.Wt. | 289.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N014656 |
| CAS No | NA |
| Mol.F. | C27H22N6O5 |
| Mol.Wt. | 510.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014657 |
| CAS No | NA |
| Mol.F. | C17H16N4O2 |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014658 |
| CAS No | NA |
| Mol.F. | C13H21N5O4S |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014659 |
| CAS No | 185847-75-0 |
| Mol.F. | C13H20N6O5S |
| Mol.Wt. | 372.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014660 |
| CAS No | NA |
| Mol.F. | C13H21N5O4S |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014661 |
| CAS No | NA |
| Mol.F. | C12H19N5O7S |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014662 |
| CAS No | NA |
| Mol.F. | C23H28N10O3 |
| Mol.Wt. | 492.5 |
| INV STATUS | CUSTOM SYNTHESIS |